Tag: Ajay Tandon

Q BioMed Inc : SeeThruEquity Issues Update on Q BioMed Inc. (QBIO)

SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it...

SeeThruEquity Issues Update on BioSig Technologies Highlighting Companys Technology Being Featured in Mayo Clinic Research

NEW YORK, NY / ACCESSWIRE / August 18, 2016 / SeeThruEquity, a leading independent equity research and corporate access firm...

SeeThru Equity Initiates Coverage of Q BioMed Inc. Price Target $3.85

Q BioMed Inc. (OTCQB:QBIO) is focused on identifying, acquiring and licensing attractive biomedical assets from small private companies and academia,...

SeeThruEquity Issues Update on DelMar Pharmaceuticals, Inc. Highlighting Recent Uplisting to Nasdaq

NEW YORK, NY / ACCESSWIRE / July 20, 2016 / SeeThruEquity, a leading New York City based independent equity research...

SeeThruEquity Issues Update on DelMar Pharmaceuticals Highlighting Partnership with MD Anderson

SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public...

SeeThruEquity Initiates Coverage of Lomiko Metals With Target Price of C$0.19

Independent equity research and corporate access firm SeeThruEquity has initiated coverage on Lomiko Metals Inc. (TSXV:LMR,OTCQX:LMRMF), with a price target...